• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建并验证一种简便的临床列线图模型预测肾细胞癌患者发生脑转移的风险。

Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients.

机构信息

Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, China.

Qingdao University Medical College, Qingdao, Shandong 266000, China.

出版信息

Biomed Res Int. 2020 Nov 17;2020:9501760. doi: 10.1155/2020/9501760. eCollection 2020.

DOI:10.1155/2020/9501760
PMID:33282957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7688358/
Abstract

Brain metastasis (BM) is a typical type of metastasis in renal cell carcinoma (RCC) patients. The early detection of BM is likely a crucial step for RCC patients to receive appropriate treatment and prolong their overall survival. The aim of this study was to identify the independent predictors of BM and construct a nomogram to predict the risk of BM. Demographic and clinicopathological data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database for RCC patients between 2010 and 2015. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors, and then, a visual nomogram was constructed. Multiple parameters were used to evaluate the discrimination and clinical value. We finally included 42577 RCC patients. Multivariate logistic regression analysis showed that histological type, tumor size, bone metastatic status, and lung metastatic status were independent BM-associated risk factors for RCC. We developed a nomogram to predict the risk of BM in patients with RCC, which showed favorable calibration with a -index of 0.924 (0.903-0.945) in the training cohort and 0.911 (0.871-0.952) in the validation cohort. The calibration curves and decision curve analysis (DCA) also demonstrated the reliability and accuracy of the clinical prediction model. The nomogram was shown to be a practical, precise, and personalized clinical tool for identifying the RCC patients with a high risk of BM, which not only will contribute to the more reasonable allocation of medical resources but will also enable a further improvements in the prognosis and quality of life of RCC patients.

摘要

脑转移(BM)是肾细胞癌(RCC)患者中典型的转移类型。早期发现 BM 可能是 RCC 患者接受适当治疗并延长总体生存时间的关键步骤。本研究旨在确定 BM 的独立预测因素,并构建一个列线图来预测 BM 的风险。从 2010 年至 2015 年的监测、流行病学和最终结果(SEER)数据库中获取 RCC 患者的人口统计学和临床病理数据。进行单因素和多因素逻辑回归分析以确定独立的危险因素,然后构建可视化列线图。使用多个参数评估鉴别力和临床价值。我们最终纳入了 42577 例 RCC 患者。多因素逻辑回归分析显示,组织学类型、肿瘤大小、骨转移状态和肺转移状态是 RCC 发生 BM 的独立相关危险因素。我们开发了一个预测 RCC 患者 BM 风险的列线图,在训练队列中的 -指数为 0.924(0.903-0.945),在验证队列中的 -指数为 0.911(0.871-0.952),显示出良好的校准度。校准曲线和决策曲线分析(DCA)也证明了临床预测模型的可靠性和准确性。该列线图是一种实用、精确且个性化的临床工具,可用于识别 BM 风险较高的 RCC 患者,这不仅有助于更合理地分配医疗资源,还有助于改善 RCC 患者的预后和生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/a378981a49c1/BMRI2020-9501760.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/9d615c1930ce/BMRI2020-9501760.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/81505ff1716a/BMRI2020-9501760.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/4516f7c8eaf0/BMRI2020-9501760.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/5b02596ea207/BMRI2020-9501760.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/b3556b9710cf/BMRI2020-9501760.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/a378981a49c1/BMRI2020-9501760.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/9d615c1930ce/BMRI2020-9501760.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/81505ff1716a/BMRI2020-9501760.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/4516f7c8eaf0/BMRI2020-9501760.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/5b02596ea207/BMRI2020-9501760.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/b3556b9710cf/BMRI2020-9501760.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3204/7688358/a378981a49c1/BMRI2020-9501760.006.jpg

相似文献

1
Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients.构建并验证一种简便的临床列线图模型预测肾细胞癌患者发生脑转移的风险。
Biomed Res Int. 2020 Nov 17;2020:9501760. doi: 10.1155/2020/9501760. eCollection 2020.
2
Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.建立并验证一个列线图模型预测老年肾细胞癌患者远处转移的风险
Front Public Health. 2022 Jan 28;9:831940. doi: 10.3389/fpubh.2021.831940. eCollection 2021.
3
Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.开发和验证用于预测转移性肾细胞癌患者总生存期的列线图。
BMC Cancer. 2020 Nov 4;20(1):1066. doi: 10.1186/s12885-020-07586-7.
4
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.肝癌骨转移的诊断和预后列线图。
BMC Cancer. 2020 Jun 1;20(1):494. doi: 10.1186/s12885-020-06995-y.
5
Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms.肾细胞癌患者的骨转移:风险、预后因素及列线图
J Oncol. 2021 May 12;2021:5575295. doi: 10.1155/2021/5575295. eCollection 2021.
6
Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.基于监测、流行病学和最终结果(SEER)计划数据的乳头状肾细胞癌患者中期至长期预后预测列线图。
Med Sci Monit. 2020 Jun 22;26:e921859. doi: 10.12659/MSM.921859.
7
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.基于人群的研究:初诊浸润性导管乳腺癌患者骨转移的风险因素、预后因素和列线图。
BMC Cancer. 2020 Nov 25;20(1):1145. doi: 10.1186/s12885-020-07635-1.
8
Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.基于人群的研究:患有骨转移肾细胞癌患者的生存预测图。
Int Braz J Urol. 2021 Mar-Apr;47(2):333-349. doi: 10.1590/S1677-5538.IBJU.2020.0195.
9
A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study.基于网络的老年早期肾细胞癌患者总生存预测模型:基于人群的研究。
J Transl Med. 2022 Feb 14;20(1):90. doi: 10.1186/s12967-022-03287-w.
10
A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma.一种用于预测和评估肾细胞癌患者淋巴转移的新型列线图
Front Oncol. 2022 Apr 11;12:851552. doi: 10.3389/fonc.2022.851552. eCollection 2022.

引用本文的文献

1
Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis.对初诊原发性骨脊柱肿瘤合并远处转移患者的风险和总体生存进行个体化评估。
Front Public Health. 2022 Aug 22;10:955427. doi: 10.3389/fpubh.2022.955427. eCollection 2022.
2
Establishment and validation of an individualized nomogram to predict distant metastasis in chondrosarcoma patients: a population-based study.建立并验证用于预测软骨肉瘤患者远处转移的个体化列线图:一项基于人群的研究
Transl Cancer Res. 2022 Feb;11(2):327-338. doi: 10.21037/tcr-21-2212.
3
Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

本文引用的文献

1
A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.一项包含美国癌症联合委员会(AJCC)分期的新型列线图能更好地预测接受手术的非小细胞肺癌患者的生存情况:一项基于大样本人群的研究。
J Oncol. 2020 May 20;2020:7863984. doi: 10.1155/2020/7863984. eCollection 2020.
2
Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.胃食管结合部 Siewert II 型腺癌转移患者的生存列线图:一项基于人群的研究。
Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):757-764. doi: 10.1080/17474124.2020.1784726. Epub 2020 Jun 30.
3
多学科免疫治疗为基础的合理组合在肾细胞癌脑转移中获得持久和稳健的疗效。
Int J Mol Sci. 2021 Jun 11;22(12):6290. doi: 10.3390/ijms22126290.
4
Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study.构建和验证预测骨肉瘤远处转移的列线图:一项回顾性研究。
J Orthop Surg Res. 2021 Mar 30;16(1):231. doi: 10.1186/s13018-021-02376-8.
Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma.
用于预测间变性甲状腺癌患者总生存期和癌症特异性生存期的预后列线图的开发与验证
PeerJ. 2020 May 21;8:e9173. doi: 10.7717/peerj.9173. eCollection 2020.
4
Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice.转移性肾细胞癌的系统治疗:治疗选择中的新挑战。
Crit Rev Oncol Hematol. 2020 Aug;152:102971. doi: 10.1016/j.critrevonc.2020.102971. Epub 2020 Jun 1.
5
Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma.晚期或转移性肾细胞癌的当前治疗方法
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-10. doi: 10.1200/EDBK_279881.
6
Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma.肾细胞癌患者发生脑转移的危险因素。
Biomed Res Int. 2020 Mar 9;2020:6836234. doi: 10.1155/2020/6836234. eCollection 2020.
7
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma.组织学亚型、肿瘤分级、肿瘤大小和种族可准确预测 T2 期肾细胞癌同步转移的概率。
Clin Genitourin Cancer. 2020 Oct;18(5):e610-e618. doi: 10.1016/j.clgc.2020.02.001. Epub 2020 Feb 8.
8
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
9
Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options.澳大利亚一线转移性肾细胞癌的治疗选择:新治疗方案的影响
Asia Pac J Clin Oncol. 2019 Nov;15 Suppl 10:3-10. doi: 10.1111/ajco.13289.
10
Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study.脑转移瘤来自肾细胞癌:一项机构研究。
Clin Genitourin Cancer. 2019 Dec;17(6):e1163-e1170. doi: 10.1016/j.clgc.2019.08.006. Epub 2019 Aug 20.